Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study.
Caio de Assis Moura TavaresLuciano César Pontes de AzevedoÁlvaro Réa NetoNiklas Söderberg CamposCristina Prata AmendolaRicardo Reinaldo BergoAmanda Christina Kozesinski-NakataniPaula Geraldes David-JoãoGlauco Adrieno WestphalMário Roberto Rezende Guimarães JúniorSuzana Margareth Ajeje LoboMarcos Roberto TavaresMarianna Deway Andrade DracoulakisGuilherme Martins de SouzaGuacyra Margarita Batista de AlmeidaOtavio Celso Eluf GebaraPablo Oscar TombaCamila Santos N AlbuquerqueMariana Castaldi Ramalho SilvaAdriano Pereira PagliaLucas Petri DamianiThiago Domingos CorreaAry Serpa NetoOtávio BerwangerFernando Godinho ZampieriPublished in: Critical care science (2023)
NCT05558098.
Keyphrases